Predicting an HLA-DPB1 expression marker based on standard DPB1 genotyping: Linkage analysis of over 32,000 samples.

The risk of acute graft-versus-host disease (GvHD) after hematopoietic stem cell transplantation is increased with donor-recipient HLA-DPB1 allele mismatching. The single-nucleotide polymorphism (SNP) rs9277534 within the 3' untranslated region (UTR) correlates with HLA-DPB1 allotype expression and serves as a marker for permissive HLA-DPB1 mismatches. Since rs9277534 is not routinely typed, we analyzed 32,681 samples of mostly European ancestry to investigate if the rs9277534 allele can be reliably imputed from standard DPB1 genotyping. We confirmed the previously-defined linkages between rs9277534 and 18 DPB1 alleles and established additional linkages for 46 DPB1 alleles. Based on these linkages, the rs9277534 allele could be predicted for 99.6% of the samples based on DPB1 genotypes (99.99% concordance). We demonstrate that 100% prediction accuracy could be achieved if the prediction utilized exon 3 sequence information. DPB1 genotyping based on exon 2 data alone allows no unambiguous rs9277534 allele prediction but was estimated to maintain 99% accuracy for samples of European descent. We conclude that DPB1 genotyping is sufficient to infer the DPB1 expression marker rs9277534 with high accuracy. This information could be used to select donors with permissive HLA-DPB1 mismatches without directly screening for rs9277534.

[1]  Roderic Guigó,et al.  The GEM mapper: fast, accurate and versatile alignment by filtration , 2012, Nature Methods.

[2]  Y. Kodera,et al.  Worldwide network for blood and marrow transplantation , 2009 .

[3]  V. Lange,et al.  Prediction of spurious HLA class II typing results using probabilistic classification. , 2016, Human immunology.

[4]  Jürgen Sauter,et al.  Cost-efficient high-throughput HLA typing by MiSeq amplicon sequencing , 2014, BMC Genomics.

[5]  J. Klein,et al.  Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation. , 2013, Blood.

[6]  Effie W Petersdorf,et al.  Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study. , 2012, The Lancet. Oncology.

[7]  Richard Apps,et al.  A Novel Variant Marking HLA-DP Expression Levels Predicts Recovery from Hepatitis B Virus Infection , 2012, Journal of Virology.

[8]  J. Tiercy.  How to select the best available related or unrelated donor of hematopoietic stem cells? , 2016, Haematologica.

[9]  Karl Frauendorfer,et al.  One million haemopoietic stem-cell transplants: a retrospective observational study. , 2015, The Lancet. Haematology.

[10]  Maria Pia Sormani,et al.  A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. , 2003, Blood.

[11]  2.7 million samples genotyped for HLA by next generation sequencing: lessons learned , 2017, BMC Genomics.

[12]  S Mackinnon,et al.  Diverging effects of HLA–DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles , 2010, Leukemia.

[13]  A. Begovich,et al.  The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. , 2007, Blood.

[14]  Barbara Bruno,et al.  Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation. , 2009, Blood.

[15]  ABO allele-level frequency estimation based on population-scale genotyping by next generation sequencing , 2016, BMC Genomics.

[16]  Effie W Petersdorf,et al.  High HLA-DP Expression and Graft-versus-Host Disease. , 2015, The New England journal of medicine.